Exclusive: Top gene therapy regulator forced out at FDA

Also: Gilead's CEO on the approval of a powerful new drug to prevent HIV

June 19, 2025 Check out STAT+

Sponsored By

Jon Kopaloff/Getty Images for The Elizabeth Taylor AIDS Foundation STAT+ | Gilead's CEO on the approval of a powerful new drug to prevent HIV The powerful shot, to be sold as Yeztugo, can prevent people from contracting HIV with just two doses a year. By Matthew Herper STAT+ | What's next for Sarepta Therapeutics with gene therapy under fire? With a tragedy in the news — the death of a second child tied to the therapy — the company faces market consequences, too. By Adam Feuerstein STAT+ | U.K. decision blocks a pair of Alzheimer's drugs from access through its national health service The NICE ruling means that the drugs, the first that can slow the decline caused by Alzheimer's, won't be available through the NHS. By Andrew Joseph Adobe STAT+ | Top gene therapy regulator forced out at FDA She had worked closely with former CBER head Peter Marks on establishing new paths for bringing gene therapies to market, particularly in rare diseases. By Jason Mast and Adam Feuerstein STAT+ | Cogent Biosciences-Blueprint Medicines tiff turns spicy on eve of immune drug study readout In this week's edition of "Adam's Biotech Scorecard," Adam looks at drugs for indolent systemic mastocytosis, a common form of an immune system disorder. By Adam Feuerstein STAT+ | What David Baker's AI biotech unicorn Xaira has been up to In this edition of STAT's AI Prognosis newsletter: A look at what David Baker's AI biotech Xaira has been up to, and more. By Brittany Trang Courtesy UC Regents STAT+ | Brain implant captures speech tone, pitch through analyzing activity Brain implant gives man with ALS his voice back, translating thoughts into speech with tone and pitch. Scientists say 'we're probably about 5 years away.' By O. Rose Broderick

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser